We are live on ! Find out more
SBIO icon

ALPS Medical Breakthroughs ETF

53 hedge funds and large institutions have $62.7M invested in ALPS Medical Breakthroughs ETF in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

726% more call options, than puts

Call options by funds: $1.8M | Put options by funds: $218K

89% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 9

39% more capital invested

Capital invested by funds: $45M → $62.7M (+$17.8M)

36% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 11

13% more funds holding

Funds holding: 4753 (+6)

2.64% more ownership

Funds ownership: 30.34%32.98% (+2.6%)

Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
15
Reduced
11
Closed
9
Calls
$1.8M
Puts
$218K
Net Calls
+$1.58M
Net Calls Change
+$1.01M

SBIO Hedge Fund Activity: Q2 2020 in Review

53 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q2 2020, worth a combined $62.7M — up 39% from $45M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new SBIO positions and 9 closed out — a net gain of 8 holders — while 15 added to existing stakes and 11 trimmed.

The largest buyer was Wells Fargo, adding an estimated $1.32M. The largest seller was Susquehanna International Group, cutting an estimated $3.17M.

  • 53 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q2 2020, up from 47 in Q1 2020.
  • Funds reported $62.7M of ALPS Medical Breakthroughs ETF stock for Q2 2020, up 39% quarter-over-quarter.
  • 17 funds opened new ALPS Medical Breakthroughs ETF positions in Q2 2020 and 9 closed out, a net change of +8 holders.
  • The largest ALPS Medical Breakthroughs ETF buyer in Q2 2020 was Wells Fargo, an estimated $1.32M added.
  • The largest ALPS Medical Breakthroughs ETF seller in Q2 2020 was Susquehanna International Group, an estimated $3.17M sold.

Based on aggregated 13F filings for Q2 2020.